Showing results (21-30 of 437) with videos related to
Sort By:
Pageof 44
Current Opinion in Rheumatology|April 23, 2003
Immunoglobulin for rheumatic diseases in the twenty-first century: take it or leave it?Yolanda Braun-Moscovici, Daniel E FurstRheumatic Diseases Clinics of North America|March 21, 2007
Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patientVeena K Ranganath, Daniel E FurstExpert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Meloxicam in rheumatoid arthritisMansoor Ahmed, Dinesh Khanna, Daniel E FurstCurrent Opinion in Nephrology and Hypertension|February 9, 2024
New guidelines and therapeutic updates for the management of lupus nephritisSheetal B Desai, Rebecca Ahdoot, Fatima Malik, et al.Lancet (London, England)|May 23, 2006
Systemic sclerosis: hypothesis-driven treatment strategiesChristina Charles, Philip Clements, Daniel E FurstExpert Opinion on Biological Therapy|May 20, 2015
Brodalumab -an IL-17RA monoclonal antibody for psoriasis and psoriatic arthritisErin Bauer, Jessica Lucier, Daniel E FurstDrug Safety|April 6, 2004
Safety of tumour necrosis factor-alpha antagonistsDinesh Khanna, Maureen McMahon, Daniel E FurstThe Journal of Rheumatology|May 5, 2007
Rationale and strategies for reevaluating the ACR20David T Felson, Daniel E Furst, Maarten BoersCurrent Rheumatology Reports|May 16, 2007
Management of interstitial lung disease in systemic sclerosis: lessons from SLS and FASTNihal Fathi, Daniel E Furst, Philip J ClementsRheumatology (Oxford, England)|October 10, 2017
Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosisDaniel E Furst, Yolanda Braun-Moscovic, Dinesh KhannaPageof 44